Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma
Clinical trial NCT03212261 · COMPLETED
Trial details
- NCT number
- NCT03212261
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-03
- Primary completion
- 2018-06-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.